Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

The effect of citrate replacement in hypocitraturic cases on the results of SWL: a preliminary prospective randomized study

Abstract

Purpose

To evaluate the possible effects of citrate replacement on the efficacy of shockwave lithotripsy (SWL) in the management of kidney stones in cases with hypocitraturia.

Methods

Forty hypocitraturic cases with renal pelvic stones were randomized into two groups; while citrate replacement has been done before and at the time of SWL in Study Group I (n: 20), SWL was performed without any additional specific management for hypocitraturia in Study Group II (n: 20). Twenty normocitraturic cases were also chosen as the control group (Group III). Data of the patients were evaluated comparatively.

Results

Patient, stone, and urinary pH characteristics of the groups were similar. Pre-SWL urinary citrate levels were 0.71 (0.1–1.3), 0.86 (0.1–1.4), and 3.12 (1.8–4.4) mmol/24 h in Group I, II, and III, respectively. Urinary citrate value increased from 0.71 (0.1–1.3) to 1.96 (1.6–4.1) mmol/24 h following replacement therapy (before and at the time of SWL) in Group I. Mean number of SW (p = 0.461), rate of stone-street formation (p = 0.146), and Double-J placement (p = 0.291) were similar in Group I and Group II. While the mean number of SWL sessions (2.27 ± 0.71 in Group I vs. 2.94 ± 0.59 in Group II; p = 0.027), and time to stone-free status [29.1 (16–47) days in Group I vs. 38.4(21–63) days in Group II; p = 0.043], was significantly different between study groups, these parameters were found similar between Group I and Group III.

Conclusions

In our study, the patients with hypocitraturia, who did receive replacement therapy, tended to require lower number of SWL sessions and became stone free in a shorter period than the others who underwent SWL without any specific management of hypocitraturia.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Menon M, Mahle CJ (1983) Urinary citrate excretion in patients with renal calculi. J Urol 129:1158–1160

  2. 2.

    Pak CY (1987) Citrate and renal calculi. Miner Electrolyte Metab 13:257–266

  3. 3.

    Ettinger B, Pak CY, Citron JT, Thomas C, Adams-Huet B, Vangessel A (1997) Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. J Urol 158(6):2069–2073

  4. 4.

    Fine JK, Pak CY, Preminger GM (1995) Effect of medical management and residual fragments on recurrent stone formation following shock wave lithotripsy. J Urol 153(1):27–32

  5. 5.

    Soygur T, Akbay A, Kupeli S (2002) Effect of potassium citrate therapy on stone recurrence and residual fragments after shockwave lithotripsy in lower caliceal calcium oxalate urolithiasis: a randomized controlled trial. J Endourol 16(3):149–152

  6. 6.

    Ferrandino MN, Monga M, Preminger GM (2009) Adjuvant therapy after surgical stone management. Adv Chronic Kidney Dis 16(1):52–59

  7. 7.

    Kang DE, Maloney MM, Haleblian GE, Springhart WP, Honeycutt EF, Eisenstein EL, Marguet CG, Preminger GM (2007) Effect of medical management on recurrent stone formation following percutaneous nephrolithotomy. J Urol 177(5):1785-1788; discussion 1788–1789

  8. 8.

    Robinson MR, Leitao VA, Haleblian GE, Scales CD Jr, Chandrashekar A, Pierre SA, Preminger GM (2009) Impact of long-term potassium citrate therapy on urinary profiles and recurrent stone formation. J Urol 181(3):1145–1150

  9. 9.

    Moe OW, Pearle MS, Sakhaee K (2011) Pharmacotherapy of urolithiasis: evidence from clinical trials. Kidney Int 79(4):385–392

  10. 10.

    Levy FL, Adams-Huet B, Pak CY (1995) Ambulatory evaluation of nephrolithiasis: an update of a 1980 protocol. Am J Med 98:50–59

  11. 11.

    Caudarella R, Vescini F (2009) Urinary citrate and renal stone disease: the preventive role of alkali citrate treatment. Arch Ital Urol Androl 81(3):182–187

  12. 12.

    Goldberg H, Grass L, Vogl R, Rapoport A, Oreopoulos DG (1989) Urine citrate and renal stone disease. CMAJ 141(3):217–221

  13. 13.

    Rudman D, Kutner MH, Redd SC 2nd, Waters WC 4th, Gerron GG, Bleier J (1982) Hypocitraturia in calcium nephrolithiasis. J Clin Endocrinol Metab 55(6):1052–1057

  14. 14.

    Sarica K, Erturhan S, Yurtseven C, Yagci F (2006) Effect of potassium citrate therapy on stone recurrence and regrowth after extracorporeal shockwave lithotripsy in children. J Endourol 20(11):875–879

  15. 15.

    Cicerello E, Merlo F, Gambaro G, Maccatrozzo L, Fandella A, Baggio B, Anselmo G (1994) Effect of alkaline citrate therapy on clearance of residual renal stone fragments after extracorporeal shock wave lithotripsy in sterile calcium and infection nephrolithiasis patients. J Urol 151(1):5–9

  16. 16.

    Johrde LG, Cocks FH (1986) Effect of pH on the microhardness of renal calculi. J Biomed Mater Res 20(7):945–950

  17. 17.

    Akers SR, Cocks FH, Weinerth JL (1987) Extracorporeal shock wave lithotripsy: the use of chemical treatments for improved stone comminution. J Urol 138(5):1295–1300

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Correspondence to Rahim Horuz.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Göktaş, C., Horuz, R., Akça, O. et al. The effect of citrate replacement in hypocitraturic cases on the results of SWL: a preliminary prospective randomized study. Int Urol Nephrol 44, 1357–1362 (2012). https://doi.org/10.1007/s11255-012-0190-4

Download citation

Keywords

  • Urolithiasis
  • Citrate
  • SWL
  • Treatment outcome